Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
This story is reported by Yahoo Finance. Read what other outlets are saying below, then open the original report for full details.